The New England journal of medicine, 384(7), 599-609. Massachussetts Medical Society New England Journal of Medicine, 384(7), 599-609. MASSACHUSETTS MEDICAL SOC
NEW ENGLAND JOURNAL OF MEDICINE r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname New England Journal of Medicine, 380(24), 2295-2306. MASSACHUSETTS MEDICAL SOC
American Journal of Nephrology, 46(6), 462-472. KARGER AMERICAN JOURNAL OF NEPHROLOGY r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname
De Zeeuw, D; Akizawa, T; Audhya, P; Bakris, GL; Chin, M; Christ-Schmidt, H; et al.(2013). Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. New England Journal of Medicine, 369(26), 2492-2503. doi: 10.1056/NEJMoa1306033. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/9gd0g1x9
Parving, Hans-Henrik; Brenner, Barry M.; McMurray, John J.V.; de Zeeuw, Dick; Haffner, Steven M.; Solomon, Scott D.; Chaturvedi, Nish; Persson, Frederik; Desai, Akshay S.; Nicolaides, Maria; Richard, Alexia; Xiang, Zhihua; Brunel, Patrick; Pfeffer, Marc A.; for the ALTITUDE, incl.; Allemann, Yves (2012). Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes. New England journal of medicine NEJM, 367(23), pp. 2204-2213. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1208799 NEW ENGLAND JOURNAL OF MEDICINE r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname New England Journal of Medicine, 367(23), 2204-2213. MASSACHUSETTS MEDICAL SOC Parving, H-H, Brenner, B M, McMurray, J J V, de Zeeuw, D, Haffner, S M, Solomon, S D, Chaturvedi, N, Persson, F, Desai, A S, Nicolaides, M, Richard, A, Xiang, Z, Brunel, P, Pfeffer, M A & ALTITUDE Investigators 2012, ' Cardiorenal end points in a trial of aliskiren for type 2 diabetes ', Briefings from the New England Journal of Medicine (Spanish Edition), vol. 367, no. 23, pp. 2204-13 . https://doi.org/10.1056/NEJMoa1208799